Insulin Syringes Market Size (2024 - 2029)

Insulin Syringes Market Analysis

The Insulin Syringes Market is expected to register a CAGR of more than 2% during the forecast period and a revenue of USD 2.3 billion in the forecast period.

COVID-19 substantially influenced the syringe industry due to an increase in vaccine development, which resulted in higher demand for syringes. Because the pandemic had upset the whole healthcare system, the sector faced a scarcity of syringes that met the needs of the enormous patient pool. For example, according to a UN report published in November 2021, if approximately seven billion people require two doses of coronavirus vaccine over the vaccination period, a shortage of at least one billion syringes is possible if manufacturing does not improve. However, the market is moving now that the pandemic's limitations have been loosened and the spread has decreased.

• Diabetes is a chronic disorder characterized by high blood glucose levels caused by an inability to efficiently generate or use insulin. Type-1 diabetes and type-2 diabetes are the two most common kinds of diabetes. Insulin treatment is essential for patients with type 1 diabetes because it replaces the insulin the body does not make. Insulin therapy is required for people with type 2 diabetes or gestational diabetes if other therapies, such as diabetes drugs and lifestyle modifications, are unable to keep blood glucose levels within the recommended range. Diabetes therapy tries to keep blood glucose levels healthy to avoid short- and long-term problems such as cardiovascular disease, renal disease, blindness, and lower limb amputation. Insulin syringes are designed for self-injection and provide a dependable insulin solution. An insulin syringe comprises three parts: a needle, a barrel, and a plunger. To lessen the discomfort of the injection, needles are typically short and thin.

Insulin Syringes Industry Segmentation

Insulin syringes are used for self-injection and come in a variety of sizes to help administer various insulin dosages. Insulin Syringes Market is segmented into geography (North America, Europe, Latin America, Middle East and Africa, and Asia-Pacific). The report offers the value (in USD) and volume (in units) for the above segments. Further, the report will cover a segment-wise breakdown (value and volume) for all the countries covered under the Table of Contents.